Federal award
PLUS THERAPEUTICS, INC.
HT94252411035
Assistance
Obligated and Ceiling
- Obligated (net)
- $2,985,093.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $2,985,093.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- PLUS THERAPEUTICS, INC. · NUN2VLR3MZD6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- PLUS THERAPEUTICS, INC. · NUN2VLR3MZD6
- Awarding agency
- Department of Defense · sub-agency 97DH · office HT9425
- Funding agency
- Department of Defense · sub-agency 97DH
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- HT94252411035
- Award type code
- 04
- Actions
- 4 · Aug 23, 2024 to Jul 29, 2026
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 29, 2026 | FY2026 | P00003 | EX | $0.00 | — |
| Mar 31, 2026 | FY2026 | P00002 | EX | $0.00 | — |
| Jul 28, 2025 | FY2025 | P00001 | EX | $0.00 | — |
| Aug 23, 2024 | FY2024 | 0 | A1 | $2,985,093.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.